BG61605B1 - Метод за получаване на формотерол и съединения от същатагрупа - Google Patents

Метод за получаване на формотерол и съединения от същатагрупа Download PDF

Info

Publication number
BG61605B1
BG61605B1 BG97576A BG9757693A BG61605B1 BG 61605 B1 BG61605 B1 BG 61605B1 BG 97576 A BG97576 A BG 97576A BG 9757693 A BG9757693 A BG 9757693A BG 61605 B1 BG61605 B1 BG 61605B1
Authority
BG
Bulgaria
Prior art keywords
compound
formula
straight
solvent
alkyl group
Prior art date
Application number
BG97576A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG97576A (bg
Inventor
Jan W. Trofast
Edib Jakupovic
Lena K. Mansson
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of BG97576A publication Critical patent/BG97576A/bg
Publication of BG61605B1 publication Critical patent/BG61605B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
BG97576A 1990-09-26 1993-03-24 Метод за получаване на формотерол и съединения от същатагрупа BG61605B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process
PCT/SE1991/000643 WO1992005147A1 (en) 1990-09-26 1991-09-25 New process for preparing formoterol and related compounds

Publications (2)

Publication Number Publication Date
BG97576A BG97576A (bg) 1994-03-31
BG61605B1 true BG61605B1 (bg) 1998-01-30

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97576A BG61605B1 (bg) 1990-09-26 1993-03-24 Метод за получаване на формотерол и съединения от същатагрупа

Country Status (28)

Country Link
EP (1) EP0550612B1 (pt)
JP (1) JP2801401B2 (pt)
KR (1) KR0179639B1 (pt)
AT (1) ATE134990T1 (pt)
AU (1) AU652386B2 (pt)
BG (1) BG61605B1 (pt)
CA (1) CA2091343C (pt)
CZ (1) CZ284256B6 (pt)
DE (1) DE69117768T2 (pt)
DK (1) DK0550612T3 (pt)
EE (1) EE02979B1 (pt)
ES (1) ES2084831T3 (pt)
FI (1) FI111714B (pt)
GR (1) GR3020134T3 (pt)
HK (1) HK52297A (pt)
HU (1) HU214054B (pt)
IE (1) IE74387B1 (pt)
IS (1) IS1684B (pt)
LT (1) LT3813B (pt)
LV (1) LV10770B (pt)
NO (1) NO301709B1 (pt)
PL (1) PL166434B1 (pt)
PT (1) PT99051B (pt)
RU (1) RU2079486C1 (pt)
SE (1) SE9003057D0 (pt)
SG (1) SG43150A1 (pt)
SK (1) SK22793A3 (pt)
WO (1) WO1992005147A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US6040344A (en) * 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
DK0938467T3 (da) * 1996-11-11 2002-10-07 Sepracor Inc Fremgangsmåde til fremstilling af optisk rene isomerer af formoterol
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
DE10290563D2 (de) * 2001-02-22 2004-04-29 Universitaetsklinikum Charite Mittel zur Hemmung von Tumorzellen
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
JP2011501204A (ja) * 2007-10-29 2011-01-06 ジェネリクス・(ユーケー)・リミテッド 新規なクロマトグラフィー方法
CA2723981A1 (en) 2008-05-13 2009-11-19 Astrazeneca Ab New compounds 273
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250A (zh) * 2022-09-02 2022-11-22 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (pt) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
HK52297A (en) 1997-05-02
CA2091343C (en) 2002-07-09
LV10770B (en) 1996-04-20
JPH06501262A (ja) 1994-02-10
CA2091343A1 (en) 1992-03-27
ATE134990T1 (de) 1996-03-15
FI111714B (fi) 2003-09-15
EP0550612B1 (en) 1996-03-06
DE69117768T2 (de) 1996-08-29
NO931058D0 (no) 1993-03-23
SK22793A3 (en) 1993-07-07
CZ284256B6 (cs) 1998-10-14
PL166434B1 (pl) 1995-05-31
EP0550612A1 (en) 1993-07-14
PT99051A (pt) 1992-08-31
HU9300867D0 (en) 1993-06-28
CZ44293A3 (en) 1994-01-19
AU652386B2 (en) 1994-08-25
FI931333A (fi) 1993-04-22
LT3813B (en) 1996-03-25
LTIP1715A (en) 1995-07-25
JP2801401B2 (ja) 1998-09-21
SG43150A1 (en) 1997-10-17
KR0179639B1 (ko) 1999-05-15
AU8652091A (en) 1992-04-15
HUT65912A (en) 1994-07-28
IS1684B (is) 1998-02-24
GR3020134T3 (en) 1996-08-31
SE9003057D0 (sv) 1990-09-26
LV10770A (lv) 1995-08-20
RU2079486C1 (ru) 1997-05-20
NO931058L (no) 1993-03-23
EE02979B1 (et) 1997-04-15
BG97576A (bg) 1994-03-31
ES2084831T3 (es) 1996-05-16
PT99051B (pt) 1999-02-26
DK0550612T3 (da) 1996-07-22
IS3756A7 (is) 1992-03-27
WO1992005147A1 (en) 1992-04-02
DE69117768D1 (de) 1996-04-11
NO301709B1 (no) 1997-12-01
HU214054B (en) 1997-12-29
FI931333A0 (fi) 1993-03-25
IE913373A1 (en) 1992-04-08
IE74387B1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
BG61605B1 (bg) Метод за получаване на формотерол и съединения от същатагрупа
US5434304A (en) Process for preparing formoterol and related compounds
HU228197B1 (en) Stable salts of 3,3-diphenylpropylamines derivatives and preparation thereof
FR2493848A2 (fr) Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
JPS59118766A (ja) シス,エンド−2−アザビシクロ〔5.3.0〕デカン−3−カルボン酸の誘導体およびその製法
HU188353B (en) Process for producing new xanthine derivatives
JP2852681B2 (ja) 2―アミノ―7―ヒドロキシテトラリンカルボキシアルキルエーテル類およびその製造方法
US4131686A (en) Novel benzylalcohol derivatives and processes for preparing the same
Sletzinger et al. Potent decarboxylase inhibitors. Analogs of methyldopa1
KR100224330B1 (ko) 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산
FR2483929A1 (fr) Nouvelles adenosines n6-substituees utiles comme medicaments antihypertenseurs, compositions therapeutiques et formes pharmaceutiques les contenant, et leur procede de preparation
US4451473A (en) 3,7-Diazabicyclo [3.3.1] nonanes having anti-arrhythmic activity
EP0074903A2 (fr) Dérivés d'amino-2 tétrahydro-1,2,3,4 naphtalène, leur préparation et leur application en thérapeutique
JPS6136830B2 (pt)
CA1063619A (fr) Procede de preparation de nouveaux acides benzylamino alcanoiques et les produits qui en resultent
EP0101633B1 (en) Pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives
HU177107B (en) Process for producing new 1-phenyl-ethanolamine derivatives of antyflogistic activity
WO1999062865A1 (en) Haloethyl-2-[ (2,6-dichlorophenyl) amino] phenylacetoxyacetate derivatives and their use as an intermediate to synthesize aceclofenac
HU195204B (en) Process for the diastereoselective reduction of 3-amino-1-benzoxepin-5/2/+/-ones
GB2067195A (en) 2-aminomethyl-6-halo-phenols their production and pharmaceutical composition containing them
FR2530236A1 (fr) Nouveaux derives aminoalkyl naphtaleniques, leurs sels d'addition d'acide et le procede de preparation ainsi que l'application en therapeutique de ces derives et sels
EP0178073A1 (en) amide compounds, process for preparing the same and pharmaceutical compositions containing the same
PL82685B1 (en) Dibenzazepine derivatives and their preparation[ie34441b1]
US3960944A (en) 8-Carboxamide dibenzobicyclo(3.2.1)octadienes
CS247575B1 (cs) Deriváty 1-fenoxy-3-fenoxyethylamino-2-propanolu a způsob jejich přípravy